Regulatory T Cells + CD 8 Differential Suppression of Tumor-Specific

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma.

  2009cited by this paper
• Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.

  2009cited by this paper
• Endoplasmic Reticulum Aminopeptidase Associated with Antigen Processing Regulates Quality of Processed Peptides Presented by MHC Class I Molecules1

  2008cited by this paper
• Regulatory T cell control of anti-tumour responses

  2008cited by this paper
• FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy

  2008cited by this paper
• Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma.

  2007cited by this paper
• The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules

  2006cited by this paper
• Tumor infiltrating Foxp3+ regulatory T‐cells are associated with recurrence in pathologic stage I NSCLC patients

  2006cited by this paper
• Effector memory T cells, early metastasis, and survival in colorectal cancer.

  2005cited by this paper
• Regulatory T Cells Suppress CD8+ T Cell Responses Induced by Direct Priming and Cross-Priming and Moderate Immunodominance Disparities

  2005cited by this paper
• Regulation of CD4+CD25+ regulatory T cell activity: it takes (IL‐)two to tango

  2005cited by this paper
• CD25+ CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production.

  2005cited by this paper
• IL-2 Regulates Perforin and Granzyme Gene Expression in CD8+ T Cells Independently of Its Effects on Survival and Proliferation1

  2005cited by this paper
• HCV core protein-expressing DNA vaccine induces a strong class I-binding peptide DTH response in mice.

  2004cited by this paper
• Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

  2004cited by this paper
• T cell avidity determines the level of CTL activation

  2004cited by this paper
• Interleukin‐2 is essential for CD4+CD25+ regulatory T cell function

  2004cited by this paper
• The three Es of cancer immunoediting.

  2004cited by this paper
• Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

  2003cited by this paper
• A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes.

  2002cited by this paper
• Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens

  2002cited by this paper
• Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses

  2001cited by this paper
• Topoisomerase I Inhibitors with an Indolocarbazole Structure Transporter as a Transporter of NB-506 and J-107088 , Resistance / Placenta-Specific , ATP-binding Cassette Identification of Breast Cancer Resistant Protein / Mitoxantrone Updated

  2001cited by this paper
• HIV Envelope Protein Inhibits MHC Class I Presentation of a Cytomegalovirus Protective Epitope1

  2001cited by this paper
• The Putative Natural Killer Decoy Early Genem04 (gp34) of Murine Cytomegalovirus Encodes an Antigenic Peptide Recognized by Protective Antiviral CD8 T Cells

  2000cited by this paper
• SYFPEITHI: database for MHC ligands and peptide motifs

  1999cited by this paper
• Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.

  1999cited by this paper
• Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses.

  1999cited by this paper
• Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectors.

  1998cited by this paper
• Minors held by majors: the H13 minor histocompatibility locus defined as a peptide/MHC class I complex.

  1997cited by this paper
• Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma

  1996cited by this paper
• The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product.

  1996cited by this paper
• Protection of mice against lethal viral infection by synthetic peptides corresponding to B- and T-cell recognition sites of influenza A hemagglutinin.

  1995cited by this paper
• LacZ inducible, antigen/MHC-specific T cell hybrids.

  1994cited by this paper
• A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

  1994cited by this paper
• Avidity for antigen can influence the helper dependence of CD8+ T lymphocytes.

  1993cited by this paper
• Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

  1993cited by this paper
• The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

  1993cited by this paper
• A naturally occurring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein.

  1992cited by this paper
• CD4 monoclonal antibody pairs for immunosuppression and tolerance induction

  1987cited by this paper
• High and low affinity IL 2 receptors: analysis by IL 2 dissociation rate and reactivity with monoclonal anti-receptor antibody PC61.

  1985cited by this paper
• Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma

  1977cited by this paper

• No citing papers are available for this paper.